Radionuclide Therapy
- Details
- Category: Discipline
- Stigbrand T; Carlsson J; Adams G (2008). Targeted Radionuclide Tumor Theray – Biological Aspects. Springer Eary, J; Brenner, W. (2007). Nuclear Medicine Therapy”. Informa healthcare USA Inc. Radionuclide Metabolic Therapy A Technologist’s Guide(2013). EANM Technologist’s Guide publications.
- Medical Imaging and Radiotherapy
- 4097
- 19634
- Radionuclide Therapy
- IPLUSO4097-19634
- 2
- 5
- 0
- 4
- Não
- Português
- The teaching methodologies for the theoretical component include presentation of content through slide projection. In the practical component, the contents will be investigated, discussed and demonstrated, under guidance, by the student himself. The UC can be completed by continuous assessment or by final exam. The final classification of the curricular unit through continuous assessment is obtained from the classifications obtained in the theoretical component (50%) and in the theoretical-practical component (50%). The theoretical component consists of two written frequencies (minimum classification in each frequency of 8 values). The TP component consists of two assessment moments (example: written work, oral presentations), with a minimum rating of 8 points each. The minimum final classification for each component (T and TP) and the final classification of the CU must be at least 9.5 points.
- Mandatory
- It is intended that the students acquire new knowledge on the several NM therapeutic procedures, in order for them to properly perform the respective technical procedures. To provide students with theoretical knowledge in Radionuclide Therapy, namely: Basic principles in Radionuclide Therapy Current clinical applications Future perspectives in Radionuclide Therapy To allow the student to understand and be able to perform the essential technical procedures associated with the several MN therapeutic procedures. To provide students with knowledge and skills in the area of Radionuclide Therapy, allowing them to collaborate with the NM physician by assisting the patient and performing technical procedures within NM therapeutics.
- Basic principles in radionuclide therapy Characteristics of radiopharmaceuticals for therapy Type of radiopharmaceuticals for radionuclide therapy Biological effects of ionizing radiation Therapy radiopharmaceuticals: internal dosimetry and biokinetics Radiation protection in radionuclides therapy Current clinical applications in radionuclides therapy Thyroid pathology Bone metastasis Radiosynovectomy Neuroendocrine tumors Hepatocellular carcinoma Lymphomas Prostate cancer Future prospects in radionuclides therapy
Descrição
Data limite
Ponderação
Teste Teórico I XX-XX-XXXX 25% Teste Teórico-Prática I
XX-XX-XXXX
25%
Teste Teórico II XX-XX-XXXX 25% Teste Teórico-Prática II
XX-XX-XXXX
25%
A componente escrita consta de duas frequências escritas e é relativa aos conteúdos teóricos. A classificação mínima em cada frequência é de 8 valores. A componente teórico-prática consta de 2 momentos de avaliação realizados durante as aulas. A classificação mínima em cada frequência teórico-prática é de 8 valores. A classificação final é calculada a partir da seguinte fórmula: CF = 0,50 T + 0,50 TP. A classificação de todos os instrumentos de avaliação é expressa numa escala de 0 a 20 valores, sendo que o valor ponderado das classificações obtidas tem de ser igual ou superior a 9,5 valores.
- Semestral
- The CU of Radionuclide Therapy aims to provide the knowledge and skills to understand the rationale underlying the therapeutic concept of Nuclear Medicine: the main procedures, radiopharmaceuticals (istotopes) and the particular care required in therapeutic procedures in Nuclear Medicine.
